TScan Therapeutics
TCRX
TCRX
80 hedge funds and large institutions have $51.8M invested in TScan Therapeutics in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
-12
Holders Change %
-13.04%
% of All Funds
1.07%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
20
Increased
26
Reduced
18
Closed
32
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
LCM
1
Lynx1 Capital Management
San Juan,
Puerto Rico
|
$11.4M |
| 2 |
2
Renaissance Technologies
New York
|
$1.15M |
| 3 |
3
Millennium Management
New York
|
$914K |
| 4 |
BI
4
BVF Inc
San Francisco,
California
|
$7.58M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$581K |
